Abstract
Background and Purpose: Reduced number and function of CD31+ circulating angiogenic cells (CACs) may explain vascular complications associated with the chronic phase stroke. The purpose of this study was to quantify CD31+ CAC paracrine function, total number and number of various subtypes of CD31+ CACs in individuals with chronic stroke compared with controls.
Methods: Peripheral blood mononuclear cells were isolated from chronic stroke participants and controls. CD31+ cells were quantified by flow cytometry, as was co-expression of CD31 in combination with CD14, CD3, CD11b, or CD34. Immunomagnetically selected CD31+ cells were cultured, and conditioned medium was used in a capillary-like network assay.
Results: Significantly lower levels of CD31+ CACs were found in stroke participants compared with controls (-24%; P=0.04). Additionally, CD31+/CD14+, CD31+/CD11b+ and CD31+/CD3+ cells were significantly lower in the chronic stroke group compared with controls (-45%, P=0.02; -47%, P=0.02 and -32%, P=0.03, respectively). There was no group effect on CD31+ CAC conditioned media-mediated capillary-like network formation.
Conclusion: CD31+ CACs and subtypes may serve as potential therapeutic targets in chronic stroke recovery.
Keywords: Circulating angiogenic cells, CD31, chronic stroke, angiogenic T cell, paracrine, angiogenesis.
[http://dx.doi.org/10.1161/CIR.0b013e31828124ad] [PMID: 23239837]
[http://dx.doi.org/10.1161/STROKEAHA.110.599977] [PMID: 20966405]
[http://dx.doi.org/10.1080/10739680802502423] [PMID: 19225985]
[http://dx.doi.org/10.1056/NEJMoa022287] [PMID: 12584367]
[http://dx.doi.org/10.1161/01.RES.0000110419.50982.1C] [PMID: 14656934]
[http://dx.doi.org/10.1111/jcmm.12370] [PMID: 25267411]
[http://dx.doi.org/10.1152/japplphysiol.00601.2010] [PMID: 20864561]
[http://dx.doi.org/10.1152/ajpheart.00592.2017] [PMID: 29167123]
[http://dx.doi.org/10.1152/ajpheart.00342.2016] [PMID: 27793853]
[http://dx.doi.org/10.1152/ajpheart.00123.2015] [PMID: 26055789]
[http://dx.doi.org/10.1161/STROKEAHA.107.484386] [PMID: 17761925]
[http://dx.doi.org/10.1161/STROKEAHA.107.489401] [PMID: 18063830]
[http://dx.doi.org/10.1161/STROKEAHA.107.499236] [PMID: 18356550]
[http://dx.doi.org/10.1186/s13045-015-0130-8] [PMID: 25888494]
[http://dx.doi.org/10.1016/j.atherosclerosis.2013.04.017] [PMID: 23701996]
[http://dx.doi.org/10.1093/cvr/cvs256] [PMID: 22865639]
[http://dx.doi.org/10.1161/01.ATV.0000114236.77009.06] [PMID: 14699017]
[http://dx.doi.org/10.1093/clinchem/18.6.499] [PMID: 4337382]
[http://dx.doi.org/10.1152/japplphysiol.00002.2019] [PMID: 31219767]
[http://dx.doi.org/10.1139/apnm-2015-0637] [PMID: 27441589]
[http://dx.doi.org/10.1152/japplphysiol.00541.2011] [PMID: 21700895]
[http://dx.doi.org/10.1152/japplphysiol.00349.2016] [PMID: 27197857]
[http://dx.doi.org/10.1002/dmrr.2398] [PMID: 23390082]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.107.694778] [PMID: 17909106]
[http://dx.doi.org/10.1161/CIRCRESAHA.111.243386] [PMID: 22343557]
[http://dx.doi.org/10.1161/STROKEAHA.111.632208] [PMID: 21980212]
[http://dx.doi.org/10.1016/j.hlc.2011.06.003] [PMID: 21767986]
[http://dx.doi.org/10.1161/01.CIR.0000058702.69484.A0] [PMID: 12615796]
[http://dx.doi.org/10.1111/eci.12009] [PMID: 23083351]
[http://dx.doi.org/10.1016/j.jacc.2013.09.019] [PMID: 24140662]
[http://dx.doi.org/10.3389/fpsyt.2019.00184] [PMID: 31031649]
[http://dx.doi.org/10.1016/j.imbio.2013.06.010] [PMID: 23932437]
[http://dx.doi.org/10.1126/science.1142883.]
[http://dx.doi.org/10.1016/j.jacc.2013.07.043] [PMID: 23973684]
[http://dx.doi.org/10.1084/jem.20120690] [PMID: 24166715]
[http://dx.doi.org/10.1177/0271678X18818298] [PMID: 30621518]
[http://dx.doi.org/10.1126/science.275.5302.964]